Finland· FI-REL-REL226
Pimafucin
A natamycin product containing natamycin, registered in Finland by Cheplapharm Arzneimittel GmbH. The same ATC class is registered in 3 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Natamycin is registered in 3 of 19 countries.
Countries holding a registration under ATC D01AA02 (natamycin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Natamycin · ATC D01AA02
3 / 19 countries
- Czechiaprice
- Finlandprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Natamycin
- Manufacturer
- Cheplapharm Arzneimittel GmbH
- Country
- Finland (FI)
- ATC code
- D01AA02
- ATC class
- Natamycin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natamycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPIMAFUCINCHEPLAPHARM Arzneimittel GmbH, Greifswald
- United KingdomNatacyn 5% ophthalmic suspensionImported (United States)
- Japanピマリシン千寿製薬
- United StatesNATACYNHarrow Eye, LLC
- PolandPimafucinCHEPLAPHARM Arzneimittel GmbH
- NorwayNatacyn
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Pimafucin
- Hungary · Pimafucin
- Poland · Pimafucin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a4b6ca7-1a4a-4095-9f48-f17202882320 GET /v1/drugs/2a4b6ca7-1a4a-4095-9f48-f17202882320?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "emulsiovoide",
"route": "Iholle",
"ddd_unit": null,
"strength": "2 %",
"atc_label": "natamysiini",
"ma_number": "2005",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL226",
"authorised_at": "1965-08-04"
}See everything about natamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.